Market value shrinks by 282 billion after grim sales forecast

The Danish pharmaceutical giant Novo Nordisk’s expectations for the year were not well-received by investors, as the company’s B-share plummeted by 17.2% on Wednesday afternoon. On Tuesday evening, Novo presented its 2025 annual report, forecasting a negative revenue growth of 5 to 13% for the year. Novo Nordisk’s market value decreased by almost 282 billion […]